Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,256 | 109,966 | 68,395 | 47,976 | 31,004 |
| Marketable Securities | 368,488 | 264,915 | 338,771 | 394,442 | 265,198 |
| Receivables | N/A | 15,000 | N/A | N/A | 577 |
| Other current assets | 947 | 3,762 | 2,537 | 135 | 856 |
| TOTAL | $510,268 | $405,317 | $419,416 | $451,273 | $302,339 |
| Non-Current Assets | |||||
| PPE Net | 50,457 | 48,134 | 13,334 | 11,881 | 10,841 |
| Investments And Advances | 362,159 | 61,434 | 152,328 | 125,187 | 162,531 |
| Other Non-Current Assets | 55,151 | 60,874 | 18,056 | 17,564 | 11,464 |
| TOTAL | $467,767 | $170,442 | $183,718 | $154,632 | $184,836 |
| Total Assets | $978,035 | $575,759 | $603,134 | $605,905 | $487,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,989 | 7,075 | 4,335 | 4,005 | 4,368 |
| Accrued Expenses | 34,867 | 33,864 | 27,502 | 22,971 | 10,330 |
| Other current liabilities | 223 | 524 | 303 | 228 | 106 |
| TOTAL | $67,767 | $85,691 | $71,343 | $92,542 | $110,617 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,576 | 37,883 | 35,260 | 61,739 | 92,552 |
| Other Non-Current Liabilities | 72,423 | 77,028 | 12,394 | 13,290 | 14,228 |
| TOTAL | $74,649 | $95,097 | $41,640 | $53,725 | $92,670 |
| Total Liabilities | $142,416 | $180,788 | $112,983 | $146,267 | $203,287 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,944 | 61,112 | 55,184 | 51,704 | 44,811 |
| Common Shares | 7 | 6 | 6 | 5 | 4 |
| Retained earnings | -754,610 | -530,752 | -383,790 | -228,982 | -128,765 |
| Other shareholders' equity | -1,485 | -552 | -4,949 | -660 | -128 |
| TOTAL | $835,619 | $394,971 | $490,151 | $459,638 | $283,888 |
| Total Liabilities And Equity | $978,035 | $575,759 | $603,134 | $605,905 | $487,175 |